PhoenixBio Company Description

PhoenixBio Co., Ltd. provides contract testing services for pharmaceutical development in Japan, the United States, Europe, and internationally.

The company offers PXB-mouse, a chimeric mouse with a humanized liver; and PXB-cells, a human hepatocyte for studies which require the use of primary human hepatocytes, such as drug metabolism, enzyme induction/inhibition, safety assessment, transporter evaluation, anti-HBV therapeutics efficacy testing, and other studies.

Its products are used in gene therapeutics, MASH/MAFLD, viral hepatitis, DMPK/toxicity, and custom transplantations applications.

PhoenixBio Co., Ltd. was incorporated in 2002 and is headquartered in Higashihiroshima, Japan.

PhoenixBio Co., Ltd.

Country	Japan
Founded	2002
Industry	Biotechnology
Sector	Healthcare
Employees	55
CEO	Masakazu Kakuni

Contact Details

Address: 3-4-1 Kagamiyama Higashihiroshima, 739-0046 Japan
Phone	81 8 2431 0016
Website	phoenixbio.co.jp

Stock Details

Ticker Symbol	6190
Exchange	Tokyo Stock Exchange
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	JPY
ISIN Number	JP3803010002
SIC Code	8731

Key Executives

Name	Position
Masakazu Kakuni	Chief Executive Officer